Initially used for diabetes, Semaglutide has demonstrated remarkable results for weight loss, helping patients lose up to 15% of their body weight when combined with diet and exercise
Methods: A narrative review in accordance with current methodological guidance was conducted on published studies concerning GLP-1RAs in PsO and PsA, including preclinical, clinical, and mechanistic research
Retatrutide side effects peak during weeks 6-8, with 28% of patients experiencing nausea at the 12mg dose
Comparison to Related Medications Understanding where Zepbound and Wegovy fit among other options helps contextualize their benefits
Avoid long-term storage in solution to prevent degradation and bacterial contamination
GLP-1 receptor agonists like semaglutide and tirzepatide have transformed type 2 diabetes and obesity management, but do GLP-1 help with rheumatoid arthritis